Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2023-03-20 00:00:00 ET · period of report 2023-01-15 · accession 0001415889-23-005234 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-20 | 2023-01-15 | KNSA | Megna Michael R | CAO | A - Grant | $9.56 | +704 | 8,118 | +9% | +$6,730 |
| DM | 2023-03-20 | 2023-03-16+ | KNSA | Megna Michael R | CAO | M - OptEx | — | +2,937 | 10.8K | +37% | — |
| DM | 2023-03-20 | 2023-03-16+ | KNSA | Megna Michael R | CAO | F - Tax | $11.21 | -856 | 10.2K | -8% | -$9,594 |
| DM | 2023-03-20 | 2023-03-16+ | KNSA | Megna Michael R | CAO | M - OptEx | $0.00 | -2,937 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2023-01-15 | A | A | 704 | $9.56 | 8,118 | D | — | — | |
| 2 | Common | Class A Common Share | 2023-03-16 | M | A | 774 | — | 8,892 | D | — | — | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 3 | Common | Class A Common Share | 2023-03-16 | F | D | 221 | $11.46 | 8,671 | D | — | — | |
| 4 | Common | Class A Common Share | 2023-03-20 | M | A | 2,163 | — | 10,834 | D | — | — | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 5 | Common | Class A Common Share | 2023-03-20 | F | D | 635 | $11.12 | 10,199 | D | — | — | |
| 6 | Derivative | Restricted Share Unit | 2023-03-16 | M | D | 774 | $0.00 | 1,549 | D | — · — to — | 774 Class A Common Share | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F3) The RSUs vest over a four year period, with 25% of the RSUs vesting on each anniversary of the date of grant, March 16, 2021. |
| 7 | Derivative | Restricted Share Unit | 2023-03-20 | M | D | 2,163 | $0.00 | 0 | D | — · — to — | 2,163 Class A Common Share | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F4) The performance criteria for these RSUs were met. The RSUs vested in a single installment on March 20, 2023; there was no expiration date for the RSUs. |